Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.

ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish v...

Full description

Autores:
Berbeo Velásquez, Yusmay Katerine
Tibaduiza García, Maria Fernanda
Tipo de recurso:
Tesis
Fecha de publicación:
2022
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/29690
Acceso en línea:
https://hdl.handle.net/10495/29690
Palabra clave:
Arthritis psoriatic
Biological therapy
Quality of life
Artritis psoriásica
Terapia biológica
Calidad de vida
Responsiveness
Psoriasis
Dermatology life quality index (DLQI)
https://id.nlm.nih.gov/mesh/D015535
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D011788
Rights
embargoedAccess
License
http://creativecommons.org/licenses/by-nc-sa/2.5/co/
id UDEA2_9f920f9ae4265cf886b0849cc2e67917
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/29690
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
title Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
spellingShingle Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
Arthritis psoriatic
Biological therapy
Quality of life
Artritis psoriásica
Terapia biológica
Calidad de vida
Responsiveness
Psoriasis
Dermatology life quality index (DLQI)
https://id.nlm.nih.gov/mesh/D015535
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D011788
title_short Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
title_full Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
title_fullStr Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
title_full_unstemmed Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
title_sort Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
dc.creator.fl_str_mv Berbeo Velásquez, Yusmay Katerine
Tibaduiza García, Maria Fernanda
dc.contributor.advisor.none.fl_str_mv Sanclemente Mesa, Gloria
Aguirre Acevedo, Daniel Camilo
dc.contributor.author.none.fl_str_mv Berbeo Velásquez, Yusmay Katerine
Tibaduiza García, Maria Fernanda
dc.subject.mesh.none.fl_str_mv Arthritis psoriatic
Biological therapy
Quality of life
Artritis psoriásica
Terapia biológica
Calidad de vida
topic Arthritis psoriatic
Biological therapy
Quality of life
Artritis psoriásica
Terapia biológica
Calidad de vida
Responsiveness
Psoriasis
Dermatology life quality index (DLQI)
https://id.nlm.nih.gov/mesh/D015535
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D011788
dc.subject.proposal.spa.fl_str_mv Responsiveness
Psoriasis
Dermatology life quality index (DLQI)
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D015535
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D011788
description ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish version of DLQI instrument in patients with psoriasis who initiate treatment with biologic therapy. Methodology: Observational, descriptive, cross-sectional study based on retrospective data of patients with psoriasis treated in a referral center in the city of Medellin. Clinical and sociodemographic variables were collected, as well as patients' quality of life. The DLQI scale was applied before and 3 months after initiating biologic therapy. To assess the change between baseline and subsequent measurements, the effect size was determined with Cohen's d-test. Results: A total of 257 patients were included. Their mean age was 52.8 years. The main subtypes of psoriasis were chronic plaque psoriasis (88.3%), psoriatic arthropathy (33.5%). The subtypes with the highest baseline mean DLQI scores were pustular psoriasis (14.2), scalp psoriasis (6.81) and palmoplantar psoriasis (5.71). Most of the patients evaluated received treatment with anti-tumor necrosis factor drugs. Both the DLQI and PASI had lower mean scores throughout follow-up. The effect size obtained by Cohen's d-test, between baseline vs. first follow-up DLQI measurement after initiation of biologic therapy was mild for psoriasis classified as mild at baseline; however, the effect size was strong for patients who had severe psoriasis at their initial evaluation. Conclusions: The Colombian Spanish version of the Dermatological Quality of Life Index (DLQI) in patients with psoriasis has a low responsiveness even though the therapy implemented in these patients was effective.
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2022-07-12T19:06:03Z
dc.date.available.none.fl_str_mv 2022-07-12T19:06:03Z
dc.date.issued.none.fl_str_mv 2022
dc.type.spa.fl_str_mv info:eu-repo/semantics/other
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_b1a7d7d4d402bcce
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/draft
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_46ec
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/COther
dc.type.local.spa.fl_str_mv Tesis/Trabajo de grado - Monografía - Especialización
format http://purl.org/coar/resource_type/c_46ec
status_str draft
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/29690
url https://hdl.handle.net/10495/29690
dc.language.iso.spa.fl_str_mv eng
language eng
dc.rights.spa.fl_str_mv info:eu-repo/semantics/embargoedAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_f1cf
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
eu_rights_str_mv embargoedAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/2.5/co/
http://purl.org/coar/access_right/c_f1cf
https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.format.extent.spa.fl_str_mv 38
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.group.spa.fl_str_mv GRID - Grupo de Investigación Dermatológica
dc.publisher.place.spa.fl_str_mv Medellín - Colombia
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/7/license_rdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/8/license.txt
https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/6/BerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdf
bitstream.checksum.fl_str_mv e2060682c9c70d4d30c83c51448f4eed
8a4605be74aa9ea9d79846c1fba20a33
fc601186fb52e018e67d2cd8279df0d1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173145871745024
spelling Sanclemente Mesa, GloriaAguirre Acevedo, Daniel CamiloBerbeo Velásquez, Yusmay KaterineTibaduiza García, Maria Fernanda2022-07-12T19:06:03Z2022-07-12T19:06:03Z2022https://hdl.handle.net/10495/29690ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish version of DLQI instrument in patients with psoriasis who initiate treatment with biologic therapy. Methodology: Observational, descriptive, cross-sectional study based on retrospective data of patients with psoriasis treated in a referral center in the city of Medellin. Clinical and sociodemographic variables were collected, as well as patients' quality of life. The DLQI scale was applied before and 3 months after initiating biologic therapy. To assess the change between baseline and subsequent measurements, the effect size was determined with Cohen's d-test. Results: A total of 257 patients were included. Their mean age was 52.8 years. The main subtypes of psoriasis were chronic plaque psoriasis (88.3%), psoriatic arthropathy (33.5%). The subtypes with the highest baseline mean DLQI scores were pustular psoriasis (14.2), scalp psoriasis (6.81) and palmoplantar psoriasis (5.71). Most of the patients evaluated received treatment with anti-tumor necrosis factor drugs. Both the DLQI and PASI had lower mean scores throughout follow-up. The effect size obtained by Cohen's d-test, between baseline vs. first follow-up DLQI measurement after initiation of biologic therapy was mild for psoriasis classified as mild at baseline; however, the effect size was strong for patients who had severe psoriasis at their initial evaluation. Conclusions: The Colombian Spanish version of the Dermatological Quality of Life Index (DLQI) in patients with psoriasis has a low responsiveness even though the therapy implemented in these patients was effective.RESUMEN: Antecedentes: La psoriasis es una enfermedad crónica que no solo se ha relacionado con pérdida de productividad laboral y ausentismo, sino también con discapacidad, depresión e ideación suicida en los pacientes afectados. El objetivo de este estudio fue evaluar la sensibilidad al cambio del instrumento DLQI en su versión en español colombiano en pacientes con psoriasis que inician tratamiento con terapia biológica. Métodos: estudio observacional, descriptivo de corte transversal basado en datos retrospectivos de pacientes con psoriasis atendidos en un centro de referencia en la ciudad de Medellín. Se recolectaron variables clínicas y sociodemográficas, así como de calidad de vida de los pacientes. Se aplicó la escala DLQI antes y 3 meses después de iniciar la terapia biológica. Para valorar el cambio entre la medición basal y las mediciones posteriores, se determinó el tamaño del efecto con la prueba “d” de Cohen. Resultados: Se incluyeron 257 pacientes. Su edad media fue de 52.8 años. Los principales subtipos de psoriasis fueron la psoriasis en placas (88.3%), la artropatía psoriásica (33,5%). Los subtipos con mayores puntajes de DLQI promedio basal fueron la psoriasis pustulosa (14.2), psoriasis en cuero cabelludo (6.81) y la psoriasis palmoplantar (5.71). La mayoría de los pacientes evaluados recibieron tratamiento con medicamentos anti-factor de necrosis tumoral. Tanto el DLQI como el PASI tuvieron menores puntuaciones promedios a lo largo del seguimiento. El tamaño del efecto obtenido por la prueba de Cohen, entre la medición basal vs el primer seguimiento del DLQI luego de iniciada la terapia biológica fue leve en el caso de las psoriasis clasificadas como leves al inicio, sin embargo, el tamaño del efecto fue fuerte para pacientes que tuvieron psoriasis grave en su evaluación inicial. Conclusiones: La versión en Español Colombiano del Índice de Calidad de Vida Dermatológica (DLQI) en pacientes con psoriasis tiene una sensibilidad baja a pesar de que la terapia instaurada en estos pacientes si fue eficaz.38application/pdfenginfo:eu-repo/semantics/draftinfo:eu-repo/semantics/otherhttp://purl.org/coar/resource_type/c_46echttp://purl.org/redcol/resource_type/COtherTesis/Trabajo de grado - Monografía - Especializaciónhttp://purl.org/coar/version/c_b1a7d7d4d402bcceinfo:eu-repo/semantics/embargoedAccesshttp://creativecommons.org/licenses/by-nc-sa/2.5/co/http://purl.org/coar/access_right/c_f1cfhttps://creativecommons.org/licenses/by-nc-sa/4.0/Arthritis psoriaticBiological therapyQuality of lifeArtritis psoriásicaTerapia biológicaCalidad de vidaResponsivenessPsoriasisDermatology life quality index (DLQI)https://id.nlm.nih.gov/mesh/D015535https://id.nlm.nih.gov/mesh/D001691https://id.nlm.nih.gov/mesh/D011788Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.GRID - Grupo de Investigación DermatológicaMedellín - ColombiaEspecialista en dermatologíaEspecializaciónFacultad de Medicina. Especialización en DermatologíaUniversidad de AntioquiaCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81051https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/7/license_rdfe2060682c9c70d4d30c83c51448f4eedMD57LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/8/license.txt8a4605be74aa9ea9d79846c1fba20a33MD58ORIGINALBerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdfBerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdfTrabajo de grado de especializaciónapplication/pdf529450https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/6/BerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdffc601186fb52e018e67d2cd8279df0d1MD5610495/29690oai:bibliotecadigital.udea.edu.co:10495/296902022-07-12 14:11:17.928Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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